Related Experiment Video
Updated: Jun 12, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome
Albert Aboseif1, Nur Neyal2, B Mark Keegan1
1Division of Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic, Rochester, MN, USA; Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
Introduction:
Tumefactive multiple sclerosis (TMS) is characterized by large brain demyelinating lesions, often with severe, disabling attacks. While MS can be preceded by a radiologically isolated syndrome (RIS), a pre-symptomatic phase in TMS is not well described.
Aim:
To characterize pre-symptomatic TMS and compare its frequency and symptomatic evolution to a non-tumefactive MS (nTMS) cohort.
Methods:
Adults (≥18 years) with ≥1 tumefactive demyelinating lesion (TDL; ≥2 cm), fulfilling 2024 McDonald Criteria were included. Pre-symptomatic TMS was defined as an incidental TDL fulfilling the 2024 pre-symptomatic MS criteria. The frequency of pre-symptomatic disease and symptomatic MS evolution were compared to a nTMS cohort matched on age at onset, sex, and disease duration, using Fisher's exact test. Among patients with pre-symptomatic MS, time to symptomatic MS conversion was compared using Kaplan-Meier (KM) analysis with log-rank testing.
Results:
Among 202 TMS patients, seven (4%) were pre-symptomatic with a median age of 51 (IQR 46, 53.5) years. Over 92 (IQR 16.5, 129.5) months, four developed new MRI lesions and one developed symptomatic MS. Four initiated disease-modifying therapy within 13.5 (IQR 1.8, 28.8) months. After matching, the frequency of pre-symptomatic disease was 3.1% (4/129; median age 38 years) in TMS compared to 5.4% (7/129; median age 38 years) in nTMS (p = 0.54). One pre-symptomatic TMS patient (25%) and one (14%) pre-symptomatic nTMS patient evolved to symptomatic MS (p = 1.0). A time-to-event analysis of symptomatic MS evolution across pre-symptomatic TMS and nTMS cohorts yielded a log-rank p = 0.67, although the overall number of observed events were limited.
Discussion:
A pre-symptomatic phase of TMS mirroring RIS may be underrecognized, warranting consideration when evaluating incidental tumefactive brain lesions. Larger studies are needed to determine whether the temporal pattern of symptomatic evolution differs between presymptomatic TMS and nTMS.
Insights
A pre-symptomatic phase of tumefactive multiple sclerosis (TMS) may be underrecognized. This study found similar frequencies and symptomatic evolution in pre-symptomatic TMS compared to non-tumefactive MS (nTMS).
Area of Science:
- Neurology
- Neuroimmunology
- Radiology
Background:
- Tumefactive multiple sclerosis (TMS) presents with large demyelinating lesions and severe attacks.
- A pre-symptomatic phase, akin to radiologically isolated syndrome (RIS) in MS, is not well-defined for TMS.
Purpose of the Study:
- To characterize the pre-symptomatic phase of TMS.
- To compare the frequency and symptomatic evolution of pre-symptomatic TMS with a matched cohort of non-tumefactive MS (nTMS).
Main Methods:
- Included adults (≥18 years) with tumefactive demyelinating lesions (TDL; ≥2 cm) meeting 2024 McDonald Criteria.
- Defined pre-symptomatic TMS as incidental TDLs meeting pre-symptomatic MS criteria.
- Compared pre-symptomatic disease frequency and symptomatic evolution to a matched nTMS cohort using Fisher's exact test and Kaplan-Meier analysis.
Main Results:
- Seven of 202 TMS patients (4%) had pre-symptomatic disease (median age 51 years).
- The frequency of pre-symptomatic disease was 3.1% in TMS versus 5.4% in nTMS (p=0.54) after matching.
- Symptomatic evolution rates were similar between pre-symptomatic TMS (25%) and nTMS (14%) cohorts (p=1.0), though event numbers were limited.
Conclusions:
- A pre-symptomatic phase of TMS, similar to RIS, may be underrecognized.
- Incidental tumefactive brain lesions warrant evaluation for a potential pre-symptomatic phase.
- Larger studies are needed to clarify differences in symptomatic evolution between pre-symptomatic TMS and nTMS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Rocky Mountain Spotted Fever
Stages of Infection

